Medicines Co. (MDCO) Tops Q4 EPS Views

February 17, 2016 7:23 AM EST

Medicines Co. (NASDAQ: MDCO) reported Q4 EPS of ($0.88), $0.66 better than the analyst estimate of ($1.54). Revenue for the quarter came in at $67.2 million versus the consensus estimate of $64.11 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings